Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation

Na minha lista:

Detalhes bibliográficos
Publicado no:	Pharmaceuticals vol. 18, no. 8 (2025), p. 1157-1189
Autor principal:	Niazi, Sarfaraz K
Publicado em:	MDPI AG
Assuntos:	Food & Drug Administration > FDA United States > US Germany Monoclonal antibodies Product quality Collaboration Real time Batch processes Process controls Biological products Pharmaceutical industry Capital expenditures Batch processing Manufacturing Cost control 19th century Product testing
Acesso em linha:	Citation/Abstract Full Text + Graphics Full Text - PDF
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Seja o primeiro a partilhar um comentário!